Reaction

Throat Clearing reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,671 reports · 83 co-occurring drugs

As of the last recalculation, Throat Clearing appears in 3,671 FAERS reports alongside 83 co-occurring drug terms. The strongest observed disproportionality signal is SACUBITRIL AND VALSARTAN (PRR 130.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sacubitril And Valsartan	1,549	130.2	131.9
Fluticasone Furoate	88	42.2	42.5
Ciclesonide	96	41.0	41.3
Teriflunomide	136	17.7	17.7
Omalizumab	243	17.2	17.3
Ipratropium Bromide	101	16.5	16.5
Methylprednisolone Acetate	22	15.7	15.7
Fluticasone Furoate And Vilanterol Trifenatate	91	14.7	14.7
Cetirizine Hydrochloride Allergy	75	14.3	14.3
Cetirizine Hydrochloride Tablets	75	14.3	14.3
Esomeprazole Magnesium Capsule, Delayed Release	33	13.0	13.0
Esomeprazole Magnesium Delayed Release Capsules	33	13.0	13.0
Esomeprazole Magnesium Dihydrate	33	12.9	13.0
Montelukast Sodium	257	12.8	12.8
Dextrose	29	12.6	12.6
Dextrose Monohydrate	29	12.4	12.4
Diphenhydramine Hydrochloride Capsule, Liquid Filled	46	12.3	12.4
Antacid	98	12.0	12.0
Fluticasone Propionate And Salmeterol Xinafoate	122	11.9	11.9
Tiotropium Bromide Inhalation Spray	23	11.7	11.7
Budesonide And Formoterol Fumarate Dihydrate	185	11.3	11.3
Budesonide	105	10.4	10.4
Mometasone	31	9.7	9.7
Calcium Carbonate	103	8.9	8.9
Vitamin E	48	8.8	8.8
Cefuroxime	17	8.5	8.5
Umeclidinium	13	8.3	8.3
Eptinezumab-Jjmr	13	8.1	8.1
Tiotropium Bromide	185	8.0	8.0
Mepolizumab	68	7.9	7.9
Pantoprazole Sodium In 0.9% Sodium Chloride	83	7.7	7.8
Pantoprazole Sodium Injection	83	7.7	7.8
Albuterol Sulfate	359	7.5	7.5
Albuterol	147	7.2	7.2
Budesonide, Glycopyrrolate, And Formoterol Fumarate	13	7.1	7.1
Cetirizine	94	7.0	7.0
Nicotine	45	6.4	6.4
Siponimod	10	6.4	6.4
Montelukast	91	6.3	6.3
Atorvastatin Calcium, Film Coated	74	6.1	6.1
Ascorbic Acid	24	5.9	5.9
Levothyroxine Sodium Anhydrous	100	5.8	5.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	41	5.7	5.7
Levodopa	12	5.6	5.7
Carvedilol	129	5.6	5.6
Iohexol	8	5.5	5.5
Cetiirizine	37	5.0	5.0
Duloxetine	60	4.9	4.9
0Xygen	41	4.8	4.8
Oxygen	41	4.8	4.8
Azelastine	15	4.8	4.8
Esomeprazole	51	4.7	4.7
Rizatriptan Benzoate	8	4.5	4.5
Empagliflozin	52	4.4	4.4
Nintedanib	24	4.4	4.4
Vitamin C	69	4.3	4.3
Tapentadol Hydrochloride	25	4.3	4.3
Aripiprazole Oral	29	4.0	4.0
Aripiprazole Orally Disintegrating	29	4.0	4.0
Amikacin	12	4.0	4.0
Epinephrine	44	3.8	3.8
Cetirizine Hydrochloride	109	3.8	3.8
Amphetamine	5	3.4	3.4
Loratadine Tablet	32	3.4	3.4
Umeclidinium Bromide And Vilanterol Trifenatate	10	3.4	3.4
Panitumumab	9	3.3	3.3
Ribociclib	17	3.1	3.1
Treprostinil	66	3.0	3.0
Insulin Lispro	71	3.0	3.0
Pancrelipase	20	2.9	2.9
Alirocumab	12	2.7	2.7
Elexacaftor, Tezacaftor, And Ivacaftor	5	2.3	2.3
Dupilumab	177	2.1	2.1
Vibegron	3	2.1	2.1
Rucaparib	3	1.9	1.9
Varenicline Tartrate	26	1.8	1.8
Tirzepatide	44	1.6	1.6
Evolocumab	44	1.5	1.5
Lifitegrast	4	1.4	1.4
Patiromer	3	1.2	1.2
Relugolix	5	1.2	1.2
Galcanezumab-Gnlm	5	0.9	0.9
Pimavanserin Tartrate	6	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.